CTKB · Cytek BioSciences Inc
United States · RS rating 88 · As of 2026-11-03
| Price | 5.96 USD |
|---|---|
| 1-day change | +3.3% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 51 / 94 / 86 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 50 / 51 / 47 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +55.9% |
| Sales growth Q/Q | +18.8% |
| Distance from 52-week high | +5.4% |
| Market cap (USD) | $547.6M |